Cleared Special

K041929 - MAMMOSITE II RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER ACCESSORIES TRAY

K041929 is an FDA 510(k) clearance for MAMMOSITE II RADIATION THERAPY SYSTEM (..., manufactured by Proxima Therapeutics, Inc.. The device is a Class 2 Radiology device with product code JAQ cleared through the Special 510(k) pathway after a 38-day FDA review.

K041929 · Proxima Therapeutics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2004
Decision
38d
Days
Class 2
Risk

K041929 is an FDA 510(k) clearance for the MAMMOSITE II RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER A.... Classified as System, Applicator, Radionuclide, Remote-controlled (product code JAQ), Class II - Special Controls.

Submitted by Proxima Therapeutics, Inc. (Alpharetta, US). The FDA issued a Cleared decision on August 26, 2004 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5700 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Proxima Therapeutics, Inc. devices

FDA 510(k) Submission Details - K041929

510(k) Number K041929 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2004
Decision Date August 26, 2004
Days to Decision 38 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 107d · This submission: 38d
Pathway characteristics
Modification to existing cleared device.

JAQ Device Classification - Class 2, Special Controls

Product Code JAQ System, Applicator, Radionuclide, Remote-controlled
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAQ System, Applicator, Radionuclide, Remote-controlled

All 143
Devices cleared under the same product code (JAQ) and FDA review panel - the closest regulatory comparables to K041929.
MICK HDR INTERSTITIAL IMPLANT ACCESSORIES
K051423 · Mick Radio-Nuclear Instruments, Inc. · Jul 2005
INTRACAVITARY MOULD APPLICATOR SET, MODEL 189.001
K041715 · Nucletron Corp. · Mar 2005
VARIAN NASOPHARYNX APPLICATOR
K042360 · Varian Medical Systems, Inc. · Feb 2005
MICROSELECTRON PDR
K041933 · Nucletron Corp. · Aug 2004
MODIFICATION TO HENSCHKE HDR CERVIX APPLICATOR AND HILARIS/NORI HDR CERVIX APPLICATOR
K040704 · Mick Radio-Nuclear Instruments, Inc. · Jun 2004
MAMMOSOURCE HIGH DOSE RATE (HDR) REMOTE AFTERLOADER
K040541 · Varian Medical Systems, Inc. · Mar 2004